BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3

• Press Releases

  Maryland Stem Cell Research Fund Awards $4.7 million to Support Innovations in Stem Cell Research

  October 3, 2025

   · 

  4 min read
• Press Releases

  AorticLab Receives FDA Approval to Initiate FLOWer™ Clinical Pivotal Investigation

  October 3, 2025

   · 

  2 min read
• Press Releases

  LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS

  October 3, 2025

   · 

  17 min read
• Press Releases

  Mitsubishi Tanabe Pharma America to Present Eight ALS Research Posters at 2025 NEALS Annual Meeting

  October 3, 2025

   · 

  9 min read
• Press Releases

  Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic

  October 3, 2025

   · 

  3 min read
• Press Releases

  Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD

  October 3, 2025

   · 

  5 min read
• Press Releases

  Nacuity Pharmaceuticals Granted U.S. FDA Breakthrough Therapy Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa

  October 3, 2025

   · 

  3 min read
• Press Releases

  Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States

  October 3, 2025

   · 

  9 min read
• Press Releases

  Incendia Therapeutics Presents Two Posters on its Lead Asset PRTH-101 in Thymic Cancers at the 15th International Thymic Malignancy Interest Group (ITMIG) Annual Meeting

  October 3, 2025

   · 

  6 min read
• Press Releases

  Kazia Therapeutics Announces 86% Reduction in Tumor Burden in Expanded-Access Case of Metastatic TNBC Patient Treated with Paxalisib-Immunotherapy Regimen

  October 3, 2025

   · 

  5 min read